BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18662303)

  • 1. Molecular aspects of rheumatoid arthritis: role of transcription factors.
    Okamoto H; Cujec TP; Yamanaka H; Kamatani N
    FEBS J; 2008 Sep; 275(18):4463-70. PubMed ID: 18662303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets of rheumatoid arthritis.
    Okamoto H; Hoshi D; Kiire A; Yamanaka H; Kamatani N
    Inflamm Allergy Drug Targets; 2008 Mar; 7(1):53-66. PubMed ID: 18473901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
    Iwamoto T; Okamoto H; Toyama Y; Momohara S
    FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signalling in rheumatoid arthritis.
    Sen M
    Rheumatology (Oxford); 2005 Jun; 44(6):708-13. PubMed ID: 15705634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.
    Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the regulation of organic cation/carnitine transporter 1 (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines.
    Maeda T; Hirayama M; Kobayashi D; Miyazawa K; Tamai I
    Drug Metab Dispos; 2007 Mar; 35(3):394-401. PubMed ID: 17142562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease.
    Daans M; Lories RJ; Luyten FP
    Arthritis Res Ther; 2008; 10(5):R115. PubMed ID: 18816401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial fibroblasts: key players in rheumatoid arthritis.
    Huber LC; Distler O; Tarner I; Gay RE; Gay S; Pap T
    Rheumatology (Oxford); 2006 Jun; 45(6):669-75. PubMed ID: 16567358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis.
    Müller-Ladner U; Pap T; Gay RE; Neidhart M; Gay S
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):102-10. PubMed ID: 16932639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of rheumatoid arthritis].
    Morović-Vergles J
    Reumatizam; 2003; 50(2):15-7. PubMed ID: 15098367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.
    Meyer LH; Franssen L; Pap T
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):969-81. PubMed ID: 16980218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role of monocyte chemoattractant protein-4 (MCP-4)/CCL13 from chondrocytes in rheumatoid arthritis.
    Iwamoto T; Okamoto H; Kobayashi S; Ikari K; Toyama Y; Tomatsu T; Kamatani N; Momohara S
    FEBS J; 2007 Sep; 274(18):4904-12. PubMed ID: 17824960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.
    Zheng W; Li R; Pan H; He D; Xu R; Guo TB; Guo Y; Zhang JZ
    Arthritis Rheum; 2009 Jul; 60(7):1957-65. PubMed ID: 19565503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of joint damage in rheumatoid arthritis.
    Bresnihan B
    J Rheumatol; 1999 Mar; 26(3):717-9. PubMed ID: 10090189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis.
    Malemud CJ
    Clin Chim Acta; 2007 Jan; 375(1-2):10-9. PubMed ID: 16893535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factors.
    Handel ML; Girgis L
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):657-75. PubMed ID: 11812014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinases as targets in rheumatoid arthritis.
    Tristano AG
    Int Immunopharmacol; 2009 Jan; 9(1):1-9. PubMed ID: 18848912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes.
    Rochas C; Hillion S; Saraux A; Mageed RA; Youinou P; Jamin C; Devauchelle V
    Arthritis Rheum; 2009 May; 60(5):1261-71. PubMed ID: 19404965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.